Publication | Closed Access

Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial

ThrombosisDual Antiplatelet TherapyCardiovascular DiseaseIschemic StrokeStrokeSecondary PreventionHematologyCerebrovascular DiseasePlatelet AntagonistPharmacotherapyNeurologyHigh-risk Ischaemic StrokeCerebral Blood FlowPublic HealthMedicineAnticoagulantAtherosclerosisIschemic Syndrome